Pancreatic Cancer Research

ResearcherUniversity of North Carolina at Chapel HillNo recent work listed

Bhalchandra Mirlekar

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9257-8536; OpenAlex author ID A5008599263. Sources: OpenAlex.

Their work

Papers
4 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 2 papers · 2021: 1 paper

Papers 4

  1. B Cell Receptor Signaling and Protein Kinase D2 Support Regulatory B Cell Function in Pancreatic Cancer. First author DOI 10.3389/fimmu.2021.745873↗
  2. Pancreatic cancer-associated inflammation drives dynamic regulation of p35 and Ebi3. First author DOI 10.1016/j.cyto.2019.154817↗
  3. B cell-Derived IL35 Drives STAT3-Dependent CD8+ T-cell Exclusion in Pancreatic Cancer. Co-author DOI 10.1158/2326-6066.cir-19-0349↗
  4. IL35 Hinders Endogenous Antitumor T-cell Immunity and Responsiveness to Immunotherapy in Pancreatic Cancer. Co-author DOI 10.1158/2326-6066.cir-17-0710↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Daniel E. Michaud · 4 shared papers, 2018–2021 · strength 0.50
  2. Yuliya Pylayeva-Gupta · 4 shared papers, 2018–2021 · strength 0.50
  3. William G. Hawkins · 1 shared paper, 2020 · strength 0.09
  4. Naim U. Rashid · 1 shared paper, 2020 · strength 0.09
  5. Nancy Porterfield Kren · 1 shared paper, 2020 · strength 0.09
  6. Jen Jen Yeh · 1 shared paper, 2020 · strength 0.09
  7. Ryan C Fields · 1 shared paper, 2020 · strength 0.09
  8. David G DeNardo · 1 shared paper, 2020 · strength 0.09
  9. Autumn J. McRee · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.